High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. - Reyes, Henry D.; Miecznikowski, Jeffrey; Gonzalez-Bosquet, Jesus; Devor, Eric J.; Zhang, Yuping; Thiel, Kristina W.; Samuelson, Megan I.; McDonald, Megan; Stephan, Jean-Marie; Hanjani, Parviz; Guntupalli, Saketh; Tewari, Krishnansu S.; et al. (Gynecologic Oncology, 2017)